Original Research

Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation

Hallinen T, Soini E, Asseburg C, Linna M, Eloranta P, Sintonen S, Kosunen M

ClinicoEconomics and Outcomes Research 2021, 13:745-755

Published Date: 13 August 2021